DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.
Morgan Stanley lowered the firm’s price target on DexCom (DXCM) to $63 from $89 and keeps an Overweight rating on the shares. Published first on ...
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...
StockStory.org on MSN
Winners And Losers Of Q3: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including DexCom ...
Medtronic plc offers stable dividends and consistent cash flow, but growth remains lackluster with revenues plateauing. Read ...
Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on ...
Amazon's second Prime-member exclusive event, Prime Big Deal Days, runs from October 7 to 8 this year. Similar to the official Prime Day in the summer, this sale offers exclusive discounts on millions ...
PERFORMANCE. We evaluate how fast a tablet can perform calculations and see how long it takes to complete different tasks. The Apple iPad Air 13" (128GB) has excellent speeds when running everyday ...
PERFORMANCE. We evaluate how fast a tablet can perform calculations and see how long it takes to complete different tasks. The Apple iPad Air 11" (128GB) Wifi + Cellular has excellent speeds when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback